Ian Smith Glides in as CEO
This article was originally published in Scrip
Glide Pharma, a specialty pharma company focused on the needle-free administration of solid dose therapeutics and vaccines, has appointed Dr Ian Smith CEO. Dr Smith, who has nearly 30 years' experience in drug delivery at companies including Glaxo, Pfizer and Andaris, most recently served as director of H12 Consulting. In 2001 he founded drug delivery company Meridica, serving as CEO until 2004 when it was acquired by Pfizer for $125 million.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.